Protection of porcine endothelial cells against apoptosis with interleukin-4

Xenotransplantation

Volumn 18, Issue 6, 2011, Pages 343-354

  Black, Sylvester M ^a   Benson, Barbara A ^a   Idossa, Damé ^a   Vercellotti, Gregory M ^b   Dalmasso, Agustin P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

accommodation; apoptosis; cytoprotection; endothelial cells; IL 4; inflammation

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLOHEXIMIDE; GALACTOSYLTRANSFERASE; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; JANUS KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; SMALL INTERFERING RNA; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE VASCULAR REJECTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL PROTECTION; DOWN REGULATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SWINE; XENOTRANSPLANTATION;

ANIMALS; AORTA; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-4; JANUS KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; SWINE; TOR SERINE-THREONINE KINASES;

EID: 83755206319     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2011.00678.x     Document Type: Article

References (57)

1. Ashkenazi A, Herbst RS,. To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 2008; 118: 1979-1990. (Pubitemid 351872316)
2. Hanahan D, Weinberg R,. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
3. Kroemer G, Galluzzi L, Brenner C,. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163. (Pubitemid 46209992)
4. Weiss JN, Korge P, Honda HM, Ping P,. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003; 93: 292-301. (Pubitemid 37048241)
5. Miller LW, Granville DJ, Narula J, McManus BM,. Apoptosis in cardiac transplant rejection. Cardiol Clin 2001; 19: 141-154. (Pubitemid 32433921)
6. Cailhier JF, Laplante P, Hebert MJ,. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am J Transplant 2006; 6: 247-253. (Pubitemid 43382159)
7. Holzknecht ZE, Kuypers KL, Plummer TB, et al., Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 2002; 91: 1135-1141. (Pubitemid 36076362)
8. Stoneman VE, Bennett MR,. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci 2004; 107: 343-354. (Pubitemid 39389301)
9. Karaflou M, Lambrinoudaki I, Christodoulakos G,. Apoptosis in atherosclerosis: a mini-review. Mini-Rev Med Chem 2008; 8: 912-918.
10. Ierino FL, Kozlowski T, Siegel JB, et al., Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439-1450. (Pubitemid 29014022)
11. Kuwaki K, Tseng YL, Dor FJ, et al., Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31. (Pubitemid 40215833)
12. Shimizu A, Hisashi Y, Kuwaki K, et al., Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 2008; 172: 1471-1481. (Pubitemid 351793341)
13. Ekser B, Kumar G, Veroux M, Cooper DK,. Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates. Curr Opin Organ Transplant 2011; 16: 222-230.
14. Gock H, Nottle M, Lew AM, et al., Genetic modification of pigs for solid organ xenotransplantation. Transplant Rev 2011; 25: 9-20.
15. Suhr BD, Black SM, Guzman-Paz M, et al., Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Xenotransplantation 2007; 14: 572-579. (Pubitemid 350076132)
16. Platt JL, Vercellotti GM, Dalmasso AP, et al., Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450-456.
17. Williams JM, Holzknecht ZE, Plummer TB, et al., Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 2004; 78: 1471-1478. (Pubitemid 39552933)
18. Koch CA, Khalpey ZI, Platt JL,. Accommodation: preventing injury in transplantation and disease. J Immunol 2004; 172: 5143-5148. (Pubitemid 38542008)
19. Grehan J, Levay-Young B, Fogelson J, et al., IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway. J Immunol 2005; 175: 1903-1910. (Pubitemid 41023097)
20. Black SM, Grehan JF, Rivard AL, et al., Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human complement. J Immunol 2006; 177: 7355-7363. (Pubitemid 44715106)
21. Chatelais M, Devalliere J, Galli C, Charreau B,. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection. Xenotransplantation 2011; 18: 108-120.
22. Black SM, Schott ME, Benson BA, et al., Interleukin-4 induces lipogenesis in porcine endothelial cells, which in turn is critical for induction of protection against complement-mediated injury. Transplant Proc 2008; 40: 638-640. (Pubitemid 351406460)
23. Black SM, Schott ME, Batdorf BH, et al., IL-4 induces protection of vascular endothelial cells against killing by complement and melittin through lipid biosynthesis. Eur J Immunol 2010; 40: 803-812.
24. Stocker CJ, Sugars KL, Harari OA, et al., TNF-alpha, IL-4, and IFN-gamma regulate differential expression of P- and E-selectin expression by porcine aortic endothelial cells. J Immunol 2000; 164: 3309-3315. (Pubitemid 30148995)
25. Tay SS, Plain KM, Bishop GA,. Role of IL-4 and Th2 responses in allograft rejection and tolerance. Curr Opin Organ Transplant 2009; 14: 16-22.
26. Ryan US, Maxwell G,. Isolation, culture and subculture of endothelial cells: mechanical methods. J Tissue Cult Methods 1986; 10: 3-8.
27. Seebach J, Schneider M, Comrack C, et al., Immortalized bone-marrow derived pig endothelial cells. Xenotransplantation 2001; 8: 48-61. (Pubitemid 32127075)
28. Polunovsky VA, Wendt CH, Ingbar DH, et al., Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res 1994; 214: 584-594. (Pubitemid 24310817)
29. Dalmasso AP, Benson BA, Johnson JS, et al., Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000; 164: 3764-3773. (Pubitemid 30169833)
30. Grehan J, Levay-Young B, Benson B, et al., αGal ligation of pig endothelial cells induces protection from complement and apoptosis independently of NF-κB and inflammatory changes. Am J Transplant 2005; 5: 712-719. (Pubitemid 40461280)
31. Woods JM, Katschke KJ Jr, Tokuhira M, et al., Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J Immunol 2000; 165: 2755-2763. (Pubitemid 30660726)
32. Woods JM, Amin MA, Katschke KJ Jr, et al., Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum Gene Ther 2002; 13: 381-393. (Pubitemid 34251503)
33. Nelms K, Keegan AD, Zamorano J, et al., The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-738. (Pubitemid 29241138)
34. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A,. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006; 17: 173-188. (Pubitemid 43816893)
35. Steele AJ, Prentice AG, Cwynarski K, et al., The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment. Blood 2010; 116: 4569-4577.
36. Pedranzini L, Dechow T, Berishaj M, et al., Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res 2006; 66: 9714-9721. (Pubitemid 44623672)
37. Dormond O, Madsen JC, Briscoe DM,. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J Biol Chem 2007; 282: 23679-23686. (Pubitemid 47311969)
38. Sarbassov DD, Ali SM, Sengupta S, et al., Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006; 22: 159-168.
39. Feldman ME, Apsel B, Uotila A, et al., Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 2009; 7: e38.
40. Kim R,. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem Biophys Res Commun 2005; 333: 336-343. (Pubitemid 40848296)
41. Lomonosova E, Chinnadurai G,. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008; 27 (Suppl 1): S2-S19.
42. Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoffbrand AV,. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1993; 85: 439-445. (Pubitemid 23349043)
43. Evans PC, Kilshaw PJ,. Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1. Transplantation 2000; 70: 928-934.
44. Soares MP, Lin Y, Anrather J, et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4: 1073-1077. (Pubitemid 28417343)
45. Ryter SW, Alam J, Choi AM,. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
46. Bernardini C, Zannoni A, Turba M, et al., Heat shock protein 70, heat shock protein 32, and vascular endothelial growth factor production and their effects on lipopolysaccharide-induced apoptosis in porcine aortic endothelial cells. Cell Stress Chaperones 2005; 10: 340-348. (Pubitemid 41813381)
47. Bernardini C, Zannoni A, Bacci M, Forni M,. Protective effect of carbon monoxide pre-conditioning on LPS-induced endothelial cell stress. Cell Stress Chaperones 2010; 15: 219-224.
48. Fitau J, Boulday G, Coulon F, et al., The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 2006; 281: 20148-20159. (Pubitemid 44065789)
49. Fujitsu Y, Fukuda K, Kimura K, et al., Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13. Invest Ophthalmol Vis Sci 2005; 46: 797-802. (Pubitemid 41321014)
50. Tozawa H, Kanki Y, Suehiro J, et al., Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoter. Mol Cell Biol 2011; 31: 2196-2209.
51. Klein NJ, Rigley KP, Callard RE,. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. Int Immunol 1993; 5: 293-301. (Pubitemid 23093167)
52. Kim J, Cheon IS, Won YJ, et al., IL-4 inhibits cell cycle progression of human umbilical vein endothelial cells by affecting p53, p21(Waf1), cyclin D1, and cyclin E expression. Mol Cells 2003; 16: 92-96. (Pubitemid 41582906)
53. Wilks A,. The JAK kinases: not just another kinase drug discovery target. Semin Cell Dev Biol 2008; 19: 319-328.
54. Alicea-Velazquez NL, Boggon TJ,. The use of structural biology in Janus kinase targeted drug discovery. Curr Drug Targets 2011; 12: 546-555.
55. Dufort FJ, Bleiman BF, Gumina MR, et al., Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol 2007; 179: 4953-4957.
56. Silva G, Cunha A, Gregoire IP, et al., The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform. J Immunol 2006; 177: 1894-1903. (Pubitemid 44092529)
57. McCarty JM, Yee EK, Deisher TA, et al., Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-kappa b-independent mechanism. FEBS Lett 1995; 372: 194-198.